Improve the Management of CVD in Patients with Diabetes
Data emerging from CVOTs of glucose lowering drugs are highlighting differences among drugs on cardiovascular disease beyond the effects of glucose lowering. Clinicians will need to change their approach to the management of patients with T2D.
January 18, 2019